IPO Listed

Scribe Therapeutics IPO

US$129m raised

Lodged 23 Jul 2026 · NASDAQ: SCTX · US$15.00 cash per share

Advisers

Scribe Therapeutics

Issuer

Legal adviser
Issuer
Scribe Therapeutics
Issuer based in
United States
Listed
24 Jul 2026
Sector
Biotech
Tags
Biotech, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.